What a Decade of Botox Does to a Face
Muscle atrophy, jaw bone density, and dose creep. What the long-term evidence shows about neuromodulators, and where the real risk sits.
Almost every conversation about Botox concerns the next three months. Will it look natural, how long will it last, what if I hate it.
Very few concern the longer question, which is what happens to a face treated every few months for ten years. That question has partial answers, and they are more interesting than either the evangelists or the sceptics allow.
Why relax anything
Because repeated movement converts temporary lines into permanent ones.
When you frown, the muscles between your brows contract and the skin folds. Young skin unfolds completely afterwards. Across years, two things change: the elastic fibers degrade, largely through sun exposure, so the skin recovers less completely, and the repeated folding etches a line into the surface.
That is the transition from a dynamic line, appearing only when you move, to a static one, present when your face is at rest. Once a line is static, relaxing the muscle no longer erases it, though it can soften it and prevent it deepening.
Which is the whole logic of the Relax lever, and it is genuinely preventive rather than corrective. You are reducing the number of folding cycles a piece of skin undergoes across a decade.
Does the muscle waste?
Partly, and the picture is more nuanced than either side of the argument admits.
Muscle atrophy following botulinum toxin is well documented, and the literature describes it as both reversible and temporary, with muscle recovering once treatment stops.
There is more specific evidence from an unexpected source. A study of musicians treated for focal hand dystonia measured muscle thickness and strength after treatment had ended, between six months and three and a half years since the last injection. Compared against matched healthy musicians, thickness was down around 10.6 percent and flexion strength around 12.5 percent.
Different context, different muscles, different doses from cosmetic facial use. What it establishes is that measurable change can persist after stopping, which is rather more than the reassuring version of this story allows.
The reassuring version has support too. Prolonged treatment can increase the duration of effect, which is why many women find they need treating less often over the years. The same weakening, framed as a benefit rather than a cost.
And the bone beneath?
A reasonable worry, and there is now a trial addressing one version of it.
The concern is mechanical. Bone maintains density partly in response to load, so a muscle pulling less might mean bone remodelling less. That is most relevant for the masseter, the chewing muscle commonly treated to slim a jawline, which generates substantial force.
A twelve-month double-blind, randomized, placebo-controlled study published in 2025 examined exactly this. Participants received one or two masseter treatments or placebo, with CT scans at baseline, day ninety and day three hundred and sixty, measuring bone density at several points in the jaw.
No clinically significant changes in mandibular bone density were found in treated participants compared with placebo or with baseline.
Genuinely reassuring, with an honest limit: it covers one or two treatments across one year. A woman treating her masseter every few months for fifteen years sits outside that data, and reviewers note that long-term consequences remain an area of active research.
Where the real risk sits
The risk sits in the pattern of use rather than in the molecule.
The failure mode of the Relax lever has little to do with Botox wearing out or damaging your face. Relax is the easiest lever to pull, so it gets pulled repeatedly while the others are ignored.
It is the most available treatment, the least intimidating, the quickest and frequently the cheapest. Which makes it the default answer to a face someone is unhappy with, regardless of whether muscle activity is what is bothering her.
A face treated on that pattern for a decade develops a characteristic look: extremely still in the upper third, with volume loss and surface change entirely untouched. That reads as odd, and the oddness comes from the imbalance rather than from the treatment.
The other pattern-level risk is dose creep. Results that soften prompt more product rather than a reassessment, and each individual increase looks perfectly reasonable.
A ten-year approach
Four principles, and they mostly point toward less.
Conservative dosing, consistently, because the goal is reduced strain while preserving expression. A face that cannot move has lost information it uses to communicate, and it tends to look treated rather than rested.
Treat when you see something rather than when the calendar says. The same principle applying to filler applies here, and if effect is lasting longer than it used to, that is the expected pattern with prolonged treatment. Stretching the interval is the correct response.
Audit it against the other levers annually. If Relax is the only thing in your plan, the plan is not a plan. Volume, surface and structure are separate mechanisms and none of them responds to a neuromodulator.
And keep a record, because almost everything about this happens between appointments. The arc from onset to peak to fade plays out across months on a face you see daily, which makes it invisible to you. Whether your interval genuinely is lengthening, whether you are using more product than three years ago, whether the result still looks like you: those are answerable with photographs and unanswerable from memory.
What nobody knows
Two honest gaps.
Decades of continuous use at cosmetic doses have not been formally studied. Botulinum toxin has been used cosmetically since the 1990s, so there are women with twenty-plus years of exposure, though not within a study designed to measure long-term structural change.
And starting young. Preventative treatment in the twenties has become common, and nobody has followed that cohort through to their fifties. The theoretical case is reasonable: fewer folding cycles across more years. The evidence for it is theoretical too.
Neither gap is a reason to avoid treatment. Both are reasons to be conservative, to keep intervals as long as results allow, and to be skeptical of anyone offering certainty about a timescale nobody has yet measured.
FAQ
Does long-term Botox permanently weaken the muscle?
Treated muscles show reduced bulk with sustained use, and the evidence points to recovery when treatment stops. The more consistent long-term issue is dose creep and over-reliance on one lever.
Does Botox affect the jaw bone?
Reduced bone density has been reported with masseter treatment specifically, where the muscle is large and the doses are high. It is not an established finding for the upper face at cosmetic doses.
Is there a safer way to use it over ten years?
Treat the smallest area that achieves the result, leave longer gaps where you can, and avoid letting one lever carry a plan that needs several.
References
- Botulinum Toxin and Muscle Atrophy: A Wanted or Unwanted Effect, 2016.
- Long-Term Muscular Atrophy and Weakness Following Cessation of Botulinum Toxin Type A Injections in the Flexor Digitorum Muscle of Musicians with Focal Hand Dystonia, 2023.
- Kostenuik P et al., "Longitudinal Computed Tomography Indicates No Negative Impact of OnabotulinumtoxinA on Mandibular Bone Density", Aesthetic Surgery Journal, 2025.
- Literature review on bone effects of masseter botulinum toxin injection, 2026.